These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19786600)
41. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661 [TBL] [Abstract][Full Text] [Related]
42. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027 [TBL] [Abstract][Full Text] [Related]
43. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018). Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816 [TBL] [Abstract][Full Text] [Related]
44. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals. Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715 [TBL] [Abstract][Full Text] [Related]
45. High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients. Darma S; Ambara A; Aman AT; Annisa L; Nurrokhman ; Nuryastuti T; Wibawa T PLoS One; 2020; 15(11):e0242542. PubMed ID: 33212470 [TBL] [Abstract][Full Text] [Related]
46. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related]
47. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Dagi HT; Findik D; Senkeles C; Arslan U Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756 [TBL] [Abstract][Full Text] [Related]
48. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility. Witthuhn F; Toubas D; Béguinot I; Aubert D; Rouger C; Remy G; Pinon JM J Clin Microbiol; 1999 Mar; 37(3):864-6. PubMed ID: 9986878 [TBL] [Abstract][Full Text] [Related]
50. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples]. Hüseyin A; Sancak B; Arikan S Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710 [TBL] [Abstract][Full Text] [Related]
51. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Marco F; Pfaller MA; Messer S; Jones RN Antimicrob Agents Chemother; 1998 Jan; 42(1):161-3. PubMed ID: 9449278 [TBL] [Abstract][Full Text] [Related]
52. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole. Fung-Tomc JC; White TC; Minassian B; Huczko E; Bonner DP Diagn Microbiol Infect Dis; 1999 Oct; 35(2):163-7. PubMed ID: 10579098 [TBL] [Abstract][Full Text] [Related]
53. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
54. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates. Swinne D; Watelle M; Nolard N Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679 [TBL] [Abstract][Full Text] [Related]
55. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750 [TBL] [Abstract][Full Text] [Related]
56. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria. Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703 [TBL] [Abstract][Full Text] [Related]
57. Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. Shin JH; Chae MJ; Song JW; Jung SI; Cho D; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW J Clin Microbiol; 2007 Aug; 45(8):2385-91. PubMed ID: 17581937 [TBL] [Abstract][Full Text] [Related]
58. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole. Nguyen MH; Yu CY J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846 [TBL] [Abstract][Full Text] [Related]
59. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV Shokri H; Sharifzadeh A J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362 [TBL] [Abstract][Full Text] [Related]